H1581

Specifying an electronic system to ensure that sales of certain products containing pseudoephedrine (PSE) do not exceed limits established under federal law

Introduced·2/27/25
Introduced Text

Establishes an electronic system to monitor sales of products containing pseudoephedrine and ephedrine to prevent exceeding federal limits.

The bill mandates an electronic system to ensure sales of products containing pseudoephedrine and ephedrine do not exceed federal limits. Retailers must electronically submit sales data to a real-time stop sale system, free of charge. The system generates alerts if sales limits are about to be exceeded, preventing such sales unless overridden due to imminent harm. Retailers must also maintain a written log or electronic record until they comply with the electronic tracking requirement. Violations are misdemeanors with fines up to $5,000. The bill preempts local laws regulating these sales.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
In committee
Next
Committee decision

Sponsors

D
1
0
Democratic CaucusRepublican Caucus

Calendar

Jul 29, 2025

1:00 PM

Joint Committee on The Judiciary Hearing

Jul 29, 2025

1:00 PM

Joint Committee on The Judiciary Hearing

History

Mar 26

House

Accompanied a study order, see H5281 (under House Rule 27)

Oct 20, 2025

Joint

Hearing scheduled for 07/29/2025 from 01:00 PM-05:10 PM in A-2

Oct 20, 2025

House

Reported by committee to Clerk’s Office for processing, will accompany a study order